Note: sources that have an asterisk require login to view the article.
In Case You Missed It!
Vaccinating Americans is critical to preventing severe illness or death from COVID-19 and ultimately stopping the pandemic. It is also essential in getting people back to work, to play and to living. To achieve widespread vaccination, engagement of the medical neighborhood is fundamental when implementing community programs designed to effectively build vaccine confidence. While we have seen encouraging vaccination rates, urgent action is necessary to reach herd immunity which experts estimate would require anywhere from 70% to 90% of the U.S. population be fully vaccinated. The reasons people are skeptical about taking the coronavirus vaccine are complex. Building vaccine confidence requires proactive and thoughtful public awareness, education and engagement of a variety of local stakeholders including community members.
Hear opening remarks from:
- Donald M. Berwick, MD, MPP · President Emeritus and Senior Fellow, Institute for Healthcare Improvement
- Senator William H. Frist, MD · Former U.S. Senate Majority Leader
- Anand Parekh, MD · Chief Medical Advisor, Bipartisan Policy Center
- Katherine H. Capps · Executive Director and Co-Founder, GTMRx Institute (Announcing the GTMRx National Task Force: Building Vaccine Confidence in the Medical Neighborhood)
Hear from the CDC’s Deputy Incident Manager for CDC’s COVID-19 Response:
- Karen Remley, MD · Director, CDC’s National Center on Birth Defects and Developmental Disabilities
Medical Neighborhood Panel discussion moderated by Susan Dentzer, Senior Policy Fellow, Robert J. Margolis Center for Health Policy at Duke University, to include:
- Sree Chaguturu, MD · Chief Medical Officer, CVS Caremark
- Lisa Fitzpatrick, MD, MPH, MPA · Founder and CEO, Grapevine Health
- Bruce Gellin, MD, MPH · President, Global Immunization, Sabin Vaccine Institute
Join BPC & GTMRx April 6, 2021 from 10:30 am – 12:00 noon ET. Register Here.
Find the answers to frequently asked questions, from an employer standpoint, that arise with the implementation of CMM. This document elucidates benefits from a plan sponsor point of view, employee population outcomes, availability of CMM to employees, resolution of medication therapy problems and more.